CMIIU
Columbus Circle Capital Corp II • NASDAQ
$9.99 ▼ -0.40% (-0.04)
CMIIU
Columbus Circle Capital Corp IINASDAQ • $9.99 ▼ -0.40% (-0.04)
Market Cap $199.80 M
52w High $10.15
52w Low $9.94
P/E 0
Volume 1.09K
Outstanding Shares 20.00M
Revenue by Products
| Product | Q3-2022 | Q4-2022 | Q2-2023 | Q3-2023 |
|---|---|---|---|---|
 Product | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Product and Service Other | $0 ▲ | $30.00M ▲ | $0 ▼ | $0 ▲ |
 Service | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
 Royalty | $20.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Market Cap $199.80 M
52w High $10.15
52w Low $9.94
P/E 0
Volume 1.09K
Outstanding Shares 20.00M
About Columbus Circle Capital Corp II
http://ii.cmlifesciencesspac.comCM Life Sciences II Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.
CEO
Gary Quin
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Shell Companies
Sector Financial Services
Went public February 11, 2026
Method of going public SPAC
Full time employees 0
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0
Revenue by Products
| Product | Q3-2022 | Q4-2022 | Q2-2023 | Q3-2023 |
|---|---|---|---|---|
| Product | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
| Product and Service Other | $0 ▲ | $30.00M ▲ | $0 ▼ | $0 ▲ |
| Service | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
| Royalty | $20.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |